GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (HKSE:02607) » Definitions » Net Income (Continuing Operations)

Shanghai Pharmaceuticals Holding Co (HKSE:02607) Net Income (Continuing Operations) : HK$5,509 Mil (TTM As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Shanghai Pharmaceuticals Holding Co's Net Income (Continuing Operations) for the three months ended in Mar. 2024 was HK$2,027 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 was HK$5,509 Mil.

Shanghai Pharmaceuticals Holding Co Net Income (Continuing Operations) Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Net Income (Continuing Operations) Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,375.41 6,644.66 7,683.01 7,808.09 5,651.09

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,224.51 1,601.25 1,648.50 232.76 2,026.57

Shanghai Pharmaceuticals Holding Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$5,509 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co  (HKSE:02607) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Shanghai Pharmaceuticals Holding Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Pharmaceuticals Holding Co (HKSE:02607) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (HKSE:02607) » Definitions » Net Income (Continuing Operations)
Comparable Companies
SHSE:600511 SZSE:000028 SHSE:600056 SHSE:600739 SZSE:000950 SHSE:603368 SZSE:002589 SZSE:002551 MCK COR CAH HSIC HKSE:01099 MIL:AMP NZSE:EBO XSWX:GALE TSE:7459 TSE:2784 PDCO TSE:9987
Traded in Other Exchanges
SHPMY:USA SHPMF:USA S1R:Germany 601607:China
Address
No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Website
https://www.sphchina.com
Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.
Executives
Blackrock, Inc. 2201 Interest of corporation controlled by you
Shanghai Industrial Investment (holdings) Company Limited 2201 Interest of corporation controlled by you
Siic International Investment Company Limited 2101 Beneficial owner
Citigroup Inc. 2201 Interest of corporation controlled by you
Lsv Asset Management 2102 Investment manager

Shanghai Pharmaceuticals Holding Co (HKSE:02607) Headlines

No Headlines